好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2009 Annual Meeting | Criteria for Stopping and Starting Multiple Sclerosis Therapy

Monday 04/27/09
06:45 AM - 08:30 AM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Breakfast Seminar
Gary Birnbaum, MD, FAAN
Participants should be familiar with some of the variables and difficulties involved in deciding when to start treatment with disease-modifying therapies in RRMS and when to stop such treatments in persons possibly no longer benefiting from them.
No CME available
Patient Care & Procedural Skills, Interpersonal and Communication Skills, Medical Knowledge
Advanced
Practitioner, Fellow, Academician, Resident
Event Timeline
06:45 AM - 07:15 AM When to Start Disease-Modifying Therapy in MS
Gary Birnbaum, MD, FAAN
06:45 AM - 08:30 AM Breakfast
07:15 AM - 07:45 AM When to Stop Disease-Modifying Therapy in MS
Aaron E. Miller, MD, FAAN
07:45 AM - 08:00 AM Break
08:00 AM - 08:30 AM Questions and Answers
Faculty Disclosures
Gary Birnbaum, MD, FAAN No disclosure on file
Aaron E. Miller, MD, FAAN Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Accordant Health Services (Caremark). Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Corevitas (formerly known as Corrona). Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MAPI=Pharma. Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Viatris (Mylan). Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen (Horizon Therapeutics). Dr. Miller has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Sterne Kessler. Dr. Miller has received publishing royalties from a publication relating to health care.